Longitudinal Study of Cognitive Variables in Women with Schizophrenia31-Year Follow-Up Study

  1. Sanguino Andrés, Rosa M.
  2. López Villalobos, José Antonio
  3. González Pablos, Emilio
  4. Guarido Rivera, Violeta
  5. González Sanguino, Clara
  6. López-Sánchez, María Victoria
  7. Vaquero-Casado, Mercedes
Revista:
The Spanish Journal of Psychology

ISSN: 1138-7416

Año de publicación: 2015

Volumen: 18

Tipo: Artículo

DOI: 10.1017/SJP.2015.100 DIALNET GOOGLE SCHOLAR lock_openAcceso abierto editor

Otras publicaciones en: The Spanish Journal of Psychology

Resumen

Objective: To longitudinally analyze the course of cognitive dimensions in schizophrenic women over a period of 31 years. Method: Accidental sampling. Developmental longitudinal design. Diagnosis according to the ICD-10. Thirty institutionalized women were evaluated using the WAIS on three separate occasions (in 1981, 1997, and 2012). The data were analyzed using a repeated measures split-plot method. Results: Patients scored one to two standard deviations below the average on the WAIS. At all three evaluation times, they scored consistently, significantly worse on Performance IQ scales than on Verbal IQ in the following sequence: Processing Speed (PS) < Perceptual Organization (PO) < Working Memory (WM) < Verbal Comprehension (VC). Longitudinally, there was a significant, linear average trend that was stable between the first and second assessments, with a significant drop in scores at the third evaluation on Performance IQ (?2 = .586) and Verbal IQ scales (?2 = .299). The same trend was observed in PS (?2 = .655) and WM (?2 = .438), while PO decreased across the three evaluations (?2 = .509) and no difference in VC was found (?2 = .126). Conclusion: Patients with schizophrenia presented with a low cognitive level. Longitudinally, they had a stable, differential profile of WAIS factors until late life, when performance dropped significantly.

Referencias bibliográficas

  • Akiko J., Eastham H., & Jeste V. (2003). Deterioro cognoscitivo en pacientes esquizofrénicos de edad avanzada [Cognitive decline in elderly schizophrenic patients]. In M. Y. Hwang & P. C. Bermanzohn (Ed.), Esquizofrenia y patologías comórbidas: Diagnóstico y tratamiento [Schizophrenia and comorbid pathologies: Diagnosis and treatment] (pp. 119–141). Barcelona, Spain: MASSON.
  • Allen D. N., Huegel S. G., Seaton B. E., Goldstein G., Gurklis J. A., & van Kammen D. P. (1998). Confirmatory factor analysis of the WAIS–R in patients with schizophrenia. Schizophrenia Research, 34, 87–94. http://dx.doi.org/10.1016/S0920-9964(98)00090-5
  • Bombin I. (2004). Análisis de la evolución de los déficits cognitivos en la esquizofrenia: Un estudio neuropsicológico transversal [Analysis of the course of cognitive decline in schizophrenia: A cross-sectional neuropsychological study] (Unpublished doctoral dissertation). Universidad de Deusto, Bilbao, Spain.
  • Fett A. K. J., Viechtbauer W., Domínguez M. D., Penn D. L., van Os J., & Krabbendam L. (2011). The relationship between neurocognition and social cognition with functional outcomes in schizophrenia: A meta-analysis. Neuroscience & Biobehavioral Reviews, 35, 573–588. http://dx.doi.org/10.1016/j.neubiorev.2010.07.001
  • Friedman J. I., Harvey P. D., Coleman T., Moriarty P. J., Bowie C., Parrella M., … Davis K. L. (2001). Six-year follow-up study of cognitive and functional status across the lifespan in schizophrenia: A comparison with Alzheimer’s disease and normal aging. American Journal of Psychiatry, 158, 1441–1448. http://dx.doi.org/10.1176/appi.ajp.158.9.1441
  • Fucetola R., Seidman L. J., Kremen W. S., Faraone S. V., Goldstein J. M., & Tsuang M. T. (2000). Age and neuropsychologic function in schizophrenia: A decline in executive abilities beyond that observed in healthy volunteers. Biological Psychiatry, 48, 137–146. http://dx.doi.org/10.1016/S0006-3223(00)00240-7
  • Garrido G., & Alberni J. (2011). ¿El deterioro en los primeros episodios de esquizofrenia es generalizado o selectivo? [Is decline in the early episodes of schizophrenia generalized or selective?]. Alzheimer. Realidades e Investigación en Demencia, 48, 18–24. http://dx.doi.org/10.5538/11371242.2011.48.18
  • Goikoetxea E., Aznar S., Cortajarena C., Ponte J., Ugarte K., & Uriarte J. (2001). El WAIS-III en pacientes esquizofrénicos. Hallazgos sobre su validez [The WAIS-III in schizophrenic patients. Validity findings]. Revista de Psicología General y Aplicada, 54, 245–257.
  • Gold S., Arndt S., Nopoulos P., O’Leary D. S., & Andreasen C. (1999). Longitudinal study of cognitive function in firstepisode and recent-onset schizophrenia. American Journal of Psychiatry, 156, 1342–1348.
  • Gold J. M., Hermann B. P., Randolph C., Wyler A. R., Goldberg T. E., & Weinberger D. R. (1994). Schizophrenia and temporal lobe epilepsy. A neuropsychological analysis. Archives of General Psychiatry, 51, 265–272. http://dx.doi.org/10.1001/archpsyc.1994.03950040009001
  • Goldstein G., & Zubin J. (1990). Neuropsychological differences between young and old schizophrenics with and without associated neurological dysfunction. Schizophrenia Research, 3, 117–126. http://dx.doi.org/10.1016/0920-9964(90)90044-8
  • Goldstein G., Allen D. N., & van Kammen D. P. (1998). Individual differences in cognitive decline in schizophrenia. American Journal of Psychiatry, 155, 1117–1118. http://dx.doi.org/10.1176/ajp.155.8.1117
  • Goldstein G., Zubin J., & Poge-Geile M. F. (1991). Hospitalization and the cognitive deficits of schizophrenia. The influence of age and education. Journal of Nervous and Mental Disease, 179, 202–205.
  • Irani F., Kalkstein S., Moberg E. A., & Moberg P. J. (2011). Neuropsychological performance in older patients with schizophrenia: A meta-analysis of cross-sectional and longitudinal studies. Schizophrenia Bulletin, 37, 1318–1326. http://dx.doi.org/10.1093/schbul/sbq057
  • Kahn R. S., & Keefe R. S. E. (2013). Schizophrenia is a cognitive illness: Time for a change in focus. JAMA Psychiatry, 70, 1107–1112. http://dx.doi.org/10.1001/jamapsychiatry.2013.155
  • Kaufman A. S., & Lichtenberger E. O. (1999). Claves para la evaluación con el WAIS-III [Essentials of WAIS-III assessment]. Madrid, Spain: TEA Ediciones.
  • Keefe R. S., & Eesley C. E. (2008). Déficits neurocognitivos [Neurocognitive deficits]. In J. A. Lieberman, T. S. Stroup, & D. O. Perkins (Eds.), Tratado de esquizofrenia [Schizophrenia treaty] (pp. 243–258). Barcelona, Spain: Ars Médica.
  • Kurtz M. M. (2005). Neurocognitive impairment across the lifespan in schizophrenia: An update. Schizophrenia Research, 74(1), 15–26. http://dx.doi.org/10.1016/j.schres.2004.07.005
  • Lawrie S. M., Olabi B., Hall J., & McIntosh A. (2011). Do we have any solid evidence of clinical utility about the pathophysiology of schizophrenia? World Psychiatry, 10(1), 19–31.
  • Mané A. (2013). ¿Neurodesarrollo o neurodegeneración? Estado actual [Neurodevelopment or neurodegeneration? Current status]. Psiquiatría Biológica, 20, 35–39. http://dx.doi.org/10.1016/j.psiq.2013.08.001
  • McGorry P., Keshavan M., Goldstone S., Amminger P., Allot K., Berk M., … Hickie I. (2014). Biomarcadores y estadificación clínica en psiquiatría [Biological markers and clinical staging in psychiatry]. World Psychiatry, 13, 211–223.
  • Montero I., & León O. G. (2007). A guide for naming research studies in Psychology. International Journal of Clinical and Health Psychology, 7, 847–862.
  • Napal O., Ojeda N., Sánchez P., Elizagárate E., Peña J., Ezcurra J., & Gutiérrez M. (2012). The course of the schizophrenia and its impact on cognition: A review of literature. Actas Españolas de Psiquiatría, 40, 198–220.
  • Nuechterlein K. H., Green M. F., Kern R. S., Baade L. E., Barch D. M., Cohen J. D., … Marder S. R. (2008). The MATRICS Consensus Cognitive Battery, part 1: Test selection, reliability, and validity. The American Journal of Psychiatry, 165, 203–213. http://dx.doi.org/10.1176/appi.ajp.2007.07010042
  • Ojeda N., Sánchez P., Elizagárate E., Soller A. B., Ezcurra J., Ramirez I., & Ballesteros J. (2007). Evolución de los síntomas cognitivos en la esquizofrenia: Una revisión de la literatura [Development of cognitive symptoms in schizophrenia: A literature review]. Actas Españolas de Psiquiatría, 35, 263–270.
  • Pardo A., & San Martín R. (1994). Análisis de datos en Psicología II [Data analysis in Psychology II]. Madrid, Spain: Pirámide.
  • Penadés R., & Gastó C. (2010). El tratamiento de rehabilitación cognitiva en la esquizofrenia [Cognitive rehabilitation treatment in schizophrenia]. Barcelona, Spain: Ed. Herder.
  • Radhakrishnan R., Butler R., & Head L. (2012). Dementia in schizophrenia. Advances in Psychiatric Treatment, 18, 144–153. http://dx.doi.org/10.1192/apt.bp.110.008268
  • Rajii T. K., & Muslant B. H. (2008). Nature and course of cognitive function in late-life schizophrenia: A systematic review. Schizophrenia Research, 102(1), 122–140. http://dx.doi.org/10.1016/j.schres.2008.03.015
  • Selma H. (2008). Neuropsicología de la esquizofrenia [The neuropsychology of schizophrenia]. Cuadernos de Neuropsicología, 2, 79–134.
  • Stone M. H. (2008). Historia y antecedentes de la esquizofrenia [History and antecedents of schizophrenia]. In J. A. Lieberman, T. S. Stroup, & D. O. Perkins (Eds.), Tratado de esquizofrenia [Schizophrenia treaty] (pp. 1–15). Barcelona, Spain: Ars Médica.
  • Trahan L. H., Stuebing K. K., Fletcher J. M., & Hiscock M. (2014). The Flynn effect: A meta-analysis. Psychological Bulletin, 140, 1332–1360. http://dx.doi.org/10.1037/a0037173
  • Wechsler D. (1982). WAIS: Escala de Inteligencia de Wechsler para Adultos: Manual técnico [WAIS: Wechsler Adult Intelligence Scale: Technical manual]. Madrid, Spain: TEA Ediciones.
  • Wechsler D. (1999). WAIS-III Escala de Inteligencia de Wechsler para Adultos-III: Manual técnico. [WAIS-III Wechsler Adult Intelligence Scale – III: Technical manual]. Madrid, Spain: TEA Ediciones.
Fuente de los datos: Dialnet